Klin Farmakol Farm. 2009;23(3):108-110

On the possibility of interactions of rocuronium with liver microsomal cytochromes P450

doc. RNDr. Eva Anzenbacherová, CSc1, Pavel Anzenbacher2, Alena Tunková2, Milan Adamus3
1 Ústav lékařské chemie a biochemie, LF UP, Olomouc
2 Ústav farmakologie LF UP a FN Olomouc
3 Klinika anesteziologie a resuscitace FN Olomouc

Aim of the study: Aim of the study was to find whether human liver microsomal cytochromes P450 interact with rocuronium in vitro.

Methods: Interaction of rocuronium with microsomal cytochromes P450 was followed spectrophotometrically using difference absorption

spectroscopy. Interaction with cytochrome P450 form CYP3A4 was studied by determination of inhibition of a CYP3A4-specific enzyme

activity (testosterone 6β-hydroxylation) by HPLC.

Results: Rocuronium interacts in vitro with human liver microsomal cytochromes P450 and inhibits effectively the CYP3A4 specific

enzyme activity.

Conclusion: Due to the fact that the CYP3A4 form is known to metabolize steroids and steroid-related compounds there is a possibility

of an influence of rocuronium-CYP3A4 interactions on other processes in the organism. Moreover, a possibility of drug interactions with

concomitantly administered drugs metabolized by CYP3A4 leading to e.g. prolongation of rocuronium effect cannot be excluded.

Keywords: rocuronium, metabolism, CYP3A4, cytochromes P450.

Published: November 6, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Anzenbacherová E, Anzenbacher P, Tunková A, Adamus M. On the possibility of interactions of rocuronium with liver microsomal cytochromes P450. Klin Farmakol Farm. 2009;23(3):108-110.
Download citation

References

  1. Proost JH, Eriksson LI, Mirakhur RK, Roest G, Wierda JMKH. Urinary, biliary and faecal excretion of rocuronium in humans. Br J Anaesthesia 2000; 85: 717-723. Go to original source... Go to PubMed...
  2. Adamus M, Gabrhelik T, Marek O. Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium. Eur J Anaesthesiology 2008; 25: 589-595. Go to original source... Go to PubMed...
  3. Ueno K. Gender differences in pharmacokinetics of anesthetics. Masui 2009; 58: 51-58. Go to PubMed...
  4. Wolbold R, Klein K, Burk O, Nussler AK, Neuhaus P, Eichelbaum M, Schwab M, Zanger UM. Sex is a major determinant of CYP3A4 expression in human liver. Hepatology 2005; 38: 978-988. Go to original source...
  5. Waxman DJ, Holloway MG. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 2009; 76: 215-228. Go to original source... Go to PubMed...
  6. Anzenbacher P, Anzenbacherová E. Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 2001; 58: 737-747. Go to original source... Go to PubMed...
  7. Guengerich FP, Martin MV, Beaune PH, Kremers P, Wolff T, Waxman DJ. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem 1986; 261(11): 5051-5060. Go to original source...
  8. Loyola YC, Braga Ade F, Potério GM, Sousa SR, Fernandes SC, Braga FS. Effect of lidocaine on the neuromuscular block produced by rocuronium: study in rat parenic-diaphragmatic nerve preparation. Rev Bras Anestesiol. 2006; 56: 147-156. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.